{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:10:41Z","timestamp":1788793841958,"version":"build-2803163510"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000738","name":"United States Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biomedical Laboratory Research and Development Service Merit Review","award":["I01-BX005336"],"award-info":[{"award-number":["I01-BX005336"]}]},{"DOI":"10.13039\/100005976","name":"Harry J. Lloyd Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005976","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institutes of Health","award":["T32CA009213"],"award-info":[{"award-number":["T32CA009213"]}]},{"name":"Institutes of Health","award":["F30CA257622"],"award-info":[{"award-number":["F30CA257622"]}]},{"name":"Institutes of Health","award":["R01AG080037"],"award-info":[{"award-number":["R01AG080037"]}]},{"name":"the University of Arizona College of Medicine Phoenix Springboard Initiative"},{"name":"VA or the United States Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In human melanoma, tumor cell-specific MHC class II expression is associated with improved response to programmed death 1 and programmed death-ligand 1 blockade; yet the direct effect of melanoma cell-specific MHC class II expression on anti-melanoma T cell responses remains largely unknown. In the clinically relevant Yale University Mouse Melanoma Exposed to Radiation (YUMMER) cell lines, MHC class II expression was IFN-\u03b3-inducible in a subset of cells. Transduction of melanoma cells with CIITA resulted in uniformly high, constitutive expression of MHC class II. YUMMER.G cells transduced with CIITA vector had increased in vivo tumor growth in wild-type mice compared to melanoma cells transduced with empty vector. YUMMER.G cells transduced with empty or CIITA vectors had the same in vivo tumor growth in RAG\u2212\/\u2212 mice, indicating that the difference in tumor growth between CIITA- and empty-transduced cells was dependent on an intact adaptive immune system. CIITA-transduced YUMMER.G tumors exhibited an increased frequency and infiltration depth of CD4+ T cells, an increased frequency of T regulatory cells, and a decreased frequency and infiltration depth of CD8+ T cells, compared to empty-transduced tumors. Antibody depletion revealed that CIITA- and empty-transduced YUMMER.G tumors were constrained by CD4+ and CD8+ T cells, but only tumor growth of CIITA-transduced cells was decreased by CD25 blockade, which primarily blocks T regulatory cell function. Overall, this work reveals a potential pro-tumorigenic role of melanoma cell-specific overexpression of MHC class II.<\/jats:p>","DOI":"10.1093\/jimmun\/vkag158","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:16:44Z","timestamp":1782757004000},"source":"Crossref","is-referenced-by-count":0,"title":["MHC class II on melanoma cells regulates the anti-tumor T cell response"],"prefix":"10.1093","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4508-3658","authenticated-orcid":false,"given":"Anne M","family":"Macy","sequence":"first","affiliation":[{"name":"Phoenix Veterans Affairs Health Care System , Phoenix, AZ,","place":["United States"]},{"name":"Department of Dermatology, University of Arizona College of Medicine\u2014Phoenix , Phoenix, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Phoenix Veterans Affairs Health Care System , Phoenix, AZ,","place":["United States"]},{"name":"Department of Dermatology, University of Arizona College of Medicine\u2014Phoenix , Phoenix, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M","family":"Thornley","sequence":"additional","affiliation":[{"name":"Phoenix Veterans Affairs Health Care System , Phoenix, AZ,","place":["United States"]},{"name":"Department of Child Health, University of Arizona College of Medicine\u2014Phoenix , Phoenix, AZ,","place":["United States"]},{"name":"Division of Critical Care, Phoenix Children\u2019s Hospital , Phoenix, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anngela C","family":"Adams","sequence":"additional","affiliation":[{"name":"Phoenix Veterans Affairs Health Care System , Phoenix, AZ,","place":["United States"]},{"name":"Department of Dermatology, University of Arizona College of Medicine\u2014Phoenix , Phoenix, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly R","family":"Stoll","sequence":"additional","affiliation":[{"name":"Department of Immunology, Mayo Clinic , Phoenix, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-9988","authenticated-orcid":false,"given":"Jessica N","family":"Lancaster","sequence":"additional","affiliation":[{"name":"Department of Immunology, Mayo Clinic , Phoenix, AZ,","place":["United States"]},{"name":"Robert and Arlene Kogod Center on Aging, Mayo Clinic , Rochester, MN,","place":["United States"]},{"name":"Department of Cancer Biology, Mayo Clinic , Scottsdale, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-8033","authenticated-orcid":false,"given":"Karen Taraszka","family":"Hastings","sequence":"additional","affiliation":[{"name":"Phoenix Veterans Affairs Health Care System , Phoenix, AZ,","place":["United States"]},{"name":"Department of Dermatology, University of Arizona College of Medicine\u2014Phoenix , Phoenix, AZ,","place":["United States"]},{"name":"University of Arizona Cancer Center, University of Arizona , Tucson, AZ,","place":["United States"]},{"name":"Department of Immunobiology, University of Arizona , Tucson, AZ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026090710433346500_vkag158-B1","doi-asserted-by":"crossref","first-page":"102330","DOI":"10.1016\/j.coi.2023.102330","article-title":"Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells","volume":"83","author":"Macy","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"2026090710433346500_vkag158-B2","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.4049\/jimmunol.1900476","article-title":"High GILT expression and an active and intact MHC class II antigen presentation pathway are associated with improved survival in melanoma","volume":"203","author":"Buetow","year":"2019","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CMR.0000000000000230","article-title":"Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma","volume":"26","author":"Nguyen","year":"2016","journal-title":"Melanoma Res"},{"key":"2026090710433346500_vkag158-B4","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat Commun"},{"key":"2026090710433346500_vkag158-B5","doi-asserted-by":"crossref","first-page":"eaar3342","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci Transl Med."},{"key":"2026090710433346500_vkag158-B6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-022-04682-5","article-title":"Landscape of helper and regulatory antitumour CD4(+) T cells in melanoma","volume":"605","author":"Oliveira","year":"2022","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B7","doi-asserted-by":"crossref","first-page":"eadi9517","DOI":"10.1126\/sciimmunol.adi9517","article-title":"CD4(+) T cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses","volume":"9","author":"Bawden","year":"2024","journal-title":"Sci Immunol"},{"key":"2026090710433346500_vkag158-B8","doi-asserted-by":"crossref","first-page":"e20221847","DOI":"10.1084\/jem.20221847","article-title":"Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes","volume":"220","author":"Lei","year":"2023","journal-title":"J Exp Med"},{"key":"2026090710433346500_vkag158-B9","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1158\/0008-5472.CAN-17-2426","article-title":"CD4(+) T-cell-mediated rejection of MHC class II-positive tumor cells is dependent on antigen secretion and indirect presentation on host APCs","volume":"78","author":"Haabeth","year":"2018","journal-title":"Cancer Res"},{"key":"2026090710433346500_vkag158-B10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B11","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1182\/bloodadvances.2020002098","article-title":"The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma","volume":"4","author":"Nagasaki","year":"2020","journal-title":"Blood Adv"},{"key":"2026090710433346500_vkag158-B12","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4049\/jimmunol.1900778","article-title":"Cancer cell-intrinsic expression of MHC class II regulates the immune microenvironment and response to anti-PD-1 therapy in lung adenocarcinoma","volume":"204","author":"Johnson","year":"2020","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B13","doi-asserted-by":"crossref","first-page":"e120360","DOI":"10.1172\/jci.insight.120360","article-title":"Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3\/FCRL6 engagement","volume":"3","author":"Johnson","year":"2018","journal-title":"JCI Insight."},{"key":"2026090710433346500_vkag158-B14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00262-018-2262-5","article-title":"The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth","volume":"68","author":"McCaw","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"2026090710433346500_vkag158-B15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","article-title":"Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors","volume":"187","author":"Ossendorp","year":"1998","journal-title":"J Exp Med"},{"key":"2026090710433346500_vkag158-B16","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.4049\/jimmunol.165.11.6047","article-title":"Tumor-specific CD4+ T cells have a major \"post-licensing\" role in CTL mediated anti-tumor immunity","volume":"165","author":"Marzo","year":"2000","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B17","first-page":"6438","article-title":"Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell","volume":"62","author":"Gao","year":"2002","journal-title":"Cancer Res"},{"key":"2026090710433346500_vkag158-B18","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J Exp Med"},{"key":"2026090710433346500_vkag158-B19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","article-title":"Primary antitumor immune response mediated by CD4+ T cells","volume":"22","author":"Corthay","year":"2005","journal-title":"Immunity"},{"key":"2026090710433346500_vkag158-B20","doi-asserted-by":"crossref","first-page":"eabe3348","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci Adv."},{"key":"2026090710433346500_vkag158-B21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J Exp Med"},{"key":"2026090710433346500_vkag158-B22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"2026090710433346500_vkag158-B23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","article-title":"Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors","volume":"42","author":"Espinosa-Carrasco","year":"2024","journal-title":"Cancer Cell"},{"key":"2026090710433346500_vkag158-B24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","article-title":"Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy","volume":"632","author":"Sultan","year":"2024","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"2026090710433346500_vkag158-B27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13073-024-01388-3","article-title":"Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients","volume":"16","author":"Zhang","year":"2024","journal-title":"Genome Med"},{"key":"2026090710433346500_vkag158-B29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12498","article-title":"The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations","volume":"29","author":"Meeth","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026090710433346500_vkag158-B30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/pcmr.12591","article-title":"UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model","volume":"30","author":"Wang","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026090710433346500_vkag158-B31","doi-asserted-by":"crossref","first-page":"101259","DOI":"10.1016\/j.tranon.2021.101259","article-title":"Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest","volume":"15","author":"Adams","year":"2022","journal-title":"Transl Oncol"},{"key":"2026090710433346500_vkag158-B32","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/1538-7445.AM2019-4622","article-title":"Abstract 4622: The YUMMER.G mouse melanoma model recapitulates the heterogeneous response to immune checkpoint blockade based on patient sex","volume":"79","author":"Ramseier","year":"2019","journal-title":"Cancer Res"},{"key":"2026090710433346500_vkag158-B33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13293-017-0154-6","article-title":"Genetic sex determination of mice by simplex PCR","volume":"8","author":"Tunster","year":"2017","journal-title":"Biol Sex Differ"},{"key":"2026090710433346500_vkag158-B34","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.jid.2021.06.005","article-title":"Solar simulated light induces cutaneous squamous cell carcinoma in inbred mice: a clinically relevant model to investigate T-cell responses","volume":"141","author":"Adams","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026090710433346500_vkag158-B35","doi-asserted-by":"crossref","first-page":"e01314","DOI":"10.1136\/jitc-2025-013148","article-title":"Structural changes from wild-type define tumor-rejecting neoantigens","volume":"13","author":"Adams","year":"2025","journal-title":"J Immunother Cancer."},{"key":"2026090710433346500_vkag158-B36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s001090050095","article-title":"Why do some females reject males? The molecular basis for male-specific graft rejection","volume":"75","author":"Scott","year":"1997","journal-title":"J Mol Med (Berl)"},{"key":"2026090710433346500_vkag158-B37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026090710433346500_vkag158-B38","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1038\/s41467-023-41101-3","article-title":"Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity","volume":"14","author":"Cui","year":"2023","journal-title":"Nat Commun"},{"key":"2026090710433346500_vkag158-B39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.immuni.2022.03.013","article-title":"Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity","volume":"55","author":"Maruhashi","year":"2022","journal-title":"Immunity"},{"key":"2026090710433346500_vkag158-B40","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.176.6.3301","article-title":"Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells","volume":"176","author":"Kohm","year":"2006","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","article-title":"Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation","volume":"190","author":"van Elsas","year":"1999","journal-title":"J Exp Med"},{"key":"2026090710433346500_vkag158-B42","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090710433346500_vkag158-B43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature13111","article-title":"Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma","volume":"507","author":"Bald","year":"2014","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00313029009063551","article-title":"Immunohistological relation between DR antigen expression on melanoma cells and infiltration by CD8+ T cells","volume":"22","author":"Hersey","year":"1990","journal-title":"Pathology"},{"key":"2026090710433346500_vkag158-B45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"2026090710433346500_vkag158-B46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1001\/jamaoncol.2025.4072","article-title":"Artificial intelligence-detected tumor-infiltrating lymphocytes and outcomes in anti-PD-1-based treated melanoma","volume":"11","author":"Schuiveling","year":"2025","journal-title":"JAMA Oncol"},{"key":"2026090710433346500_vkag158-B47","doi-asserted-by":"crossref","first-page":"e1261777","DOI":"10.1080\/2162402X.2016.1261777","article-title":"CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4(+) TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells","volume":"6","author":"Bou Nasser Eddine","year":"2017","journal-title":"Oncoimmunology"},{"key":"2026090710433346500_vkag158-B48","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/ijc.25183","article-title":"CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy","volume":"127","author":"Frangione","year":"2010","journal-title":"Int J Cancer"},{"key":"2026090710433346500_vkag158-B49","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/MPA.0000000000000160","article-title":"Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response","volume":"43","author":"Ekkirala","year":"2014","journal-title":"Pancreas"},{"key":"2026090710433346500_vkag158-B50","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1158\/1078-0432.CCR-06-0165","article-title":"CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory","volume":"12","author":"Mortara","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2026090710433346500_vkag158-B51","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.4049\/jimmunol.1501291","article-title":"Adaptive immunity to leukemia is inhibited by cross-reactive induced regulatory T cells","volume":"195","author":"Manlove","year":"2015","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B52","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.4049\/jimmunol.162.11.6663","article-title":"Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth","volume":"162","author":"Martin","year":"1999","journal-title":"J Immunol"},{"key":"2026090710433346500_vkag158-B53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat Immunol"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/6\/vkag158\/68647386\/vkag158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/6\/vkag158\/68647386\/vkag158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:43:47Z","timestamp":1788792227000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkag158\/8721661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkag158","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"vkag158"}}